Correlation Between Autonomix Medical, and Sensient Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Autonomix Medical, and Sensient Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Autonomix Medical, and Sensient Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Autonomix Medical, Common and Sensient Technologies, you can compare the effects of market volatilities on Autonomix Medical, and Sensient Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Autonomix Medical, with a short position of Sensient Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Autonomix Medical, and Sensient Technologies.

Diversification Opportunities for Autonomix Medical, and Sensient Technologies

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Autonomix and Sensient is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Autonomix Medical, Common and Sensient Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sensient Technologies and Autonomix Medical, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Autonomix Medical, Common are associated (or correlated) with Sensient Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sensient Technologies has no effect on the direction of Autonomix Medical, i.e., Autonomix Medical, and Sensient Technologies go up and down completely randomly.

Pair Corralation between Autonomix Medical, and Sensient Technologies

Given the investment horizon of 90 days Autonomix Medical, Common is expected to under-perform the Sensient Technologies. In addition to that, Autonomix Medical, is 7.86 times more volatile than Sensient Technologies. It trades about -0.07 of its total potential returns per unit of risk. Sensient Technologies is currently generating about 0.02 per unit of volatility. If you would invest  7,073  in Sensient Technologies on September 14, 2024 and sell it today you would earn a total of  665.00  from holding Sensient Technologies or generate 9.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy56.49%
ValuesDaily Returns

Autonomix Medical, Common  vs.  Sensient Technologies

 Performance 
       Timeline  
Autonomix Medical, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Autonomix Medical, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sensient Technologies 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sensient Technologies are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Sensient Technologies is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Autonomix Medical, and Sensient Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Autonomix Medical, and Sensient Technologies

The main advantage of trading using opposite Autonomix Medical, and Sensient Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Autonomix Medical, position performs unexpectedly, Sensient Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sensient Technologies will offset losses from the drop in Sensient Technologies' long position.
The idea behind Autonomix Medical, Common and Sensient Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements